Results 211 to 220 of about 26,462 (230)

Platelet P2Y12 Receptor Inhibition

American Journal Cardiovascular Drugs, 2010
David Vivas, Dominick J. Angiolillo
openaire   +1 more source

Selatogrel, a reversible P2Y12 receptor antagonist, has reduced off-target interference with haemostatic factors in a mouse thrombosis model

Thrombosis Research, 2021
Crescence Lydie, Roxane Darbousset, Laurence Panicot-Dubois   +2 more
exaly  

The role of P2Y12 receptor antagonists in thrombogenesis

2017
openaire   +1 more source

Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties

Drugs, 2013
Nicola Ferri, Alberto Corsini, Stefano Bellosta   +2 more
exaly  

Extracellular ADP augments microglial inflammasome and NF‐κB activation via the P2Y12 receptor

European Journal of Immunology, 2020
Taro Ueno, Tomohiro Morio, Hiroshi Sakuma   +2 more
exaly  

Platelets Express Activated P2Y 12 Receptor in Patients With Diabetes Mellitus

Circulation, 2017
Liang Hu, Shenghui Zhang, Hongmei Yan
exaly  

P2Y 12 Receptor Modulates Sepsis-Induced Inflammation

Arteriosclerosis, Thrombosis, and Vascular Biology, 2016
Elisabetta Liverani, Alexander Y Tsygankov, Laurie E Kilpatrick   +2 more
exaly  

International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies

Circulation, 2017
Dominick J Angiolillo, Fabiana Rollini, Robert F Storey   +2 more
exaly  

P2Y12-Receptor Antagonists and the Concept of Tailored Strategy

2016
Boukhris M, Tomasello SD, Ibn Elhadj ZI, GALASSI, ALFREDO   +3 more
openaire   +2 more sources

Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor

Journal of Thrombosis and Haemostasis, 2004
Gilles Kauffenstein
exaly